Current Medicinal Chemistry - Immunology, Endocrine & Metabolic Agents
Title: Editorial [Hot Topic: Relaxin and Related Peptides (Guest Editors: A. Ferlin and C. Foresta)]
Volume: 5 Issue: 5
Author(s): A. Ferlin and C. Foresta
Affiliation:
Export Options
About this article
Cite this article as:
Ferlin A. and Foresta C., Editorial [Hot Topic: Relaxin and Related Peptides (Guest Editors: A. Ferlin and C. Foresta)], Current Medicinal Chemistry - Immunology, Endocrine & Metabolic Agents 2005; 5 (5) . https://dx.doi.org/10.2174/156801305774322439
DOI https://dx.doi.org/10.2174/156801305774322439 |
Print ISSN 1568-0134 |
Publisher Name Bentham Science Publisher |
Online ISSN 1568-0134 |
Related Books
15
Related Articles
-
Distinctive Phenotype Identification for Breast Cancer Genotypes Among Hereditary Breast Cancer Mutated Genes
Current Bioinformatics Aptamers Against Cell Surface Receptors: Selection, Modification and Application
Current Medicinal Chemistry Signal Transduction Inhibitors in the Treatment of Breast Cancer
Current Medicinal Chemistry - Anti-Cancer Agents Nano-biotechnology and its Innovative Perspective in Diabetes Management
Mini-Reviews in Medicinal Chemistry Functional Signaling Biases in G Protein-Coupled Receptors: Game Theory and Receptor Dynamics
Mini-Reviews in Medicinal Chemistry Subtype-Selective Dopamine Receptor Radioligands for PET Imaging: Current Status and Recent Developments
Current Medicinal Chemistry Editorial [ Hot Topic: Therapeutic Potential of Peptide Motifs - Part III (Executive Editor: Jean-Claude Herve) ]
Current Pharmaceutical Design Novel Approaches in the Treatment of Antipsychotic-Induced Hyperprolactinemia: The Role of Partial Agonists of D2 Dopaminergic Receptors
Recent Patents on Endocrine, Metabolic & Immune Drug Discovery (Discontinued) Meet Our Editorial Board Member
Mini-Reviews in Medicinal Chemistry Tumor Cell Hypoxia and the Hypoxia-Response Signaling System as a Target for Prostate Cancer Therapy
Current Drug Targets Current Progress in the Development of HIV Vaccines
Current Pharmaceutical Design The Synergistic Effects of DNA-Targeted Chemotherapeutics and Histone Deacetylase Inhibitors As Therapeutic Strategies for Cancer Treatment
Current Medicinal Chemistry Efficacy and Safety of the Combination of Docetaxel (Taxotere®) with Targeted Therapies in the Treatment of Solid Malignancies
Current Drug Targets The Pentacyclic Triterpenoids in Herbal Medicines and Their Pharmacological Activities in Diabetes and Diabetic Complications
Current Medicinal Chemistry Determinants of 25-Hydroxyvitamin D Concentrations in Infants and Toddlers
Current Nutrition & Food Science Kisspeptin: Paving the Way to a New Therapeutic Avenue in Reproduction
Recent Patents on Endocrine, Metabolic & Immune Drug Discovery (Discontinued) Editorial (Thematic Issue: Personalized Cancer Treatment)
Current Molecular Pharmacology Anti-Cancer Potential of a Novel SERM Ormeloxifene
Current Medicinal Chemistry HCV-Related Rheumatic Manifestations and Therapeutic Strategies
Current Drug Targets A Comprehensive Overview of Colon Cancer- A Grim Reaper of the 21st Century
Current Medicinal Chemistry